Insider Transactions
| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jun 25, 2020 |
Chief Legal Officer
|
Chief Legal Officer | Form 4 | Other acquisition or disposition | -- | -- | 6,250 |
| Jun 24, 2020 |
Chief Legal Officer
|
Chief Legal Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 15,773 | $3.21 | 262,986 |
| Jun 23, 2020 |
Chief Medical Officer
|
Chief Medical Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 4,167 | $3.35 | 292,729 |
| Jun 23, 2020 |
Chief Medical Officer
|
Chief Medical Officer | Form 4 | Other acquisition or disposition | -- | -- | 7,226 |
| Jun 23, 2020 |
Chief Legal Officer
|
Chief Legal Officer | Form 4 | Other acquisition or disposition | -- | -- | 6,250 |
| Jun 22, 2020 |
Director
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 5,000 | $3.25 | 41,666 |
| Jun 22, 2020 |
Chief Medical Officer
|
Chief Medical Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 5,474 | $3.16 | 296,896 |
| Jun 22, 2020 |
Chief Legal Officer
|
Chief Legal Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 3,000 | $3.25 | 278,759 |
| Jun 19, 2020 |
Chief Legal Officer
|
Chief Legal Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 3,459 | $3.13 | 281,759 |
| Jun 18, 2020 |
Director
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- | 46,666 |
| Jun 18, 2020 |
Director
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 60,000 | -- | 60,000 |
| Jun 18, 2020 |
Director
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 60,000 | -- | 60,000 |
| Jun 18, 2020 |
Director
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- | 40,000 |
| Jun 18, 2020 |
Director
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 60,000 | -- | 60,000 |
| Jun 18, 2020 |
Director
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- | 32,500 |
| Jun 18, 2020 |
Director
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 60,000 | -- | 60,000 |
| Jun 18, 2020 |
Director
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- | 66,967 |
| Jun 18, 2020 |
Director
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 60,000 | -- | 60,000 |
| Jun 18, 2020 |
Director
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- | 81,069 |
| Jun 18, 2020 |
Director
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 60,000 | -- | 60,000 |
| Jun 18, 2020 |
Director
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- | 50,000 |
| Jun 18, 2020 |
Director
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 60,000 | -- | 60,000 |
| May 15, 2020 |
Chief Legal Officer
|
Chief Legal Officer | Form 4 | Other acquisition or disposition | -- | -- | 6,250 |
| May 15, 2020 |
EVP, COO & CCO
|
EVP, COO & CCO | Form 4 | Other acquisition or disposition | -- | -- | 14,139 |
| May 15, 2020 |
Director
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,000 | $3.11 | 36,967 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.